Tech Company Financing Transactions
OOVA Funding Round
On 6/12/2023, OOVA secured $10.3 million in Series A funding from Spero Ventures, Connecticut Innovations and private investors.
Transaction Overview
Company Name
Announced On
6/12/2023
Transaction Type
Venture Equity
Amount
$10,300,000
Round
Series A
Investors
Proceeds Purpose
Oova went after a new funding round when its technology reached some heavy adoption and the company received feedback from physicians asking for Oova to test additional hormones.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
750 West 8th St.
New York, NY 11704
USA
New York, NY 11704
USA
Phone
Undisclosed
Website
Email Address
Overview
OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman's fertility profile by accurately measuring key hormones over time through daily urine samples.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aparna Divaraniya
Chief Technical Officer
Jerome Scelza
Browse more venture capital transactions:
Prev: 6/12/2023: Electronic Caregiver venture capital transaction
Next: 6/12/2023: Granite Source Power venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs